14.05.2013 • News

Eli Lilly CEO Recovering After Repair to Aorta

John Lechleiter, the longtime chief executive of Eli Lilly, is recovering from successful surgery to repair a dilated aorta, the U.S. drugmaker said on Tuesday.

"Dr. Lechleiter is recovering and will be closely monitored by the medical staff over the next several days," following his surgery on Monday, the Indianapolis company said in a statement.

Lilly Chief Financial Officer Derica Rice, 48, has taken on the additional role of acting CEO during Lechleiter's absence. The company last week said Lechleiter is expected to return to work this summer. Company officials could not immediately be reached on Tuesday.

Lechleiter, 59, had no symptoms of the condition, but learned of it during recent unrelated medical testing, Lilly said. The condition involves ballooning of the large artery that carries blood from the heart to all limbs and other organs, except the lungs.

Surgery is conducted to prevent rupture of the aorta, which can be life threatening.

 

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.